458 related articles for article (PubMed ID: 33173970)
21. Metastatic tumours to the eye. Review of metastasis to the iris, ciliary body, choroid, retina, optic disc, vitreous, and/or lens capsule.
Shields CL; Kalafatis NE; Gad M; Sen M; Laiton A; Silva AMV; Agrawal K; Lally SE; Shields JA
Eye (Lond); 2023 Apr; 37(5):809-814. PubMed ID: 35306540
[TBL] [Abstract][Full Text] [Related]
22. Ocular melanoma: an overview of the current status.
Jovanovic P; Mihajlovic M; Djordjevic-Jocic J; Vlajkovic S; Cekic S; Stefanovic V
Int J Clin Exp Pathol; 2013; 6(7):1230-44. PubMed ID: 23826405
[TBL] [Abstract][Full Text] [Related]
23. Photobiology of ocular melanocytes and melanoma.
Hu DN
Photochem Photobiol; 2005; 81(3):506-9. PubMed ID: 15496134
[TBL] [Abstract][Full Text] [Related]
24. [Therapeutic attitudes to malignant melanomas of the anterior uvea. Apropos of 4 recent cases].
Vignat JP; Bourgeois H; Pon A; Jacob H; Jacquiot P
Bull Soc Ophtalmol Fr; 1983; 83(8-9):971-5. PubMed ID: 6678184
[No Abstract] [Full Text] [Related]
25. Multi-center analysis of intraocular biopsy technique and outcomes for uveal melanoma: Ocular Oncology Study Consortium report 4.
Seider MI; Berry DE; Schefler AC; Materin M; Stinnett S; Mruthyunjaya P;
Graefes Arch Clin Exp Ophthalmol; 2020 Feb; 258(2):427-435. PubMed ID: 31807898
[TBL] [Abstract][Full Text] [Related]
26. NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019.
Rao PK; Barker C; Coit DG; Joseph RW; Materin M; Rengan R; Sosman J; Thompson JA; Albertini MR; Boland G; Carson Iii WE; Contreras C; Daniels GA; DiMaio D; Durham A; Fields RC; Fleming MD; Galan A; Gastman B; Grossman K; Guild V; Johnson D; Karakousis G; Lange JR; ; Margolin K; Nath S; Olszanski AJ; Ott PA; Ross MI; Salama AK; Skitzki J; Swetter SM; Wuthrick E; McMillian NR; Engh A
J Natl Compr Canc Netw; 2020 Feb; 18(2):120-131. PubMed ID: 32023525
[TBL] [Abstract][Full Text] [Related]
27. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis.
Frenkel S; Hendler K; Pe'er J
Isr Med Assoc J; 2009 May; 11(5):280-5. PubMed ID: 19637505
[TBL] [Abstract][Full Text] [Related]
28. An Update on Oculodermal Melanocytosis and Rare Associated Conditions.
Plateroti AM; Scavella V; Abdolrahimzadeh B; Plateroti R; Rahimi S
Semin Ophthalmol; 2017; 32(4):524-528. PubMed ID: 27083007
[TBL] [Abstract][Full Text] [Related]
29. Estimating Cured Fractions of Uveal Melanoma.
Singh AD; Zabor EC; Radivoyevitch T
JAMA Ophthalmol; 2021 Feb; 139(2):174-181. PubMed ID: 33355644
[TBL] [Abstract][Full Text] [Related]
30. Update on the management of posterior uveal melanoma.
Zhao DY; Shields CL; Shields JA; Gunduz K
J Ophthalmic Nurs Technol; 1998; 17(2):66-71. PubMed ID: 9677975
[TBL] [Abstract][Full Text] [Related]
31. Clinical spectrum, treatment and outcomes of uveal melanoma in a tertiary centre.
Wong W; Sundar G; Chee C; Zhao PS; Rajagopalan R; Gopal L
Singapore Med J; 2019 Sep; 60(9):474-478. PubMed ID: 31197380
[TBL] [Abstract][Full Text] [Related]
32. [Ocular melanomas : An update].
Kalirai H; Müller PL; Jaehne D; Coupland SE
Pathologe; 2017 Nov; 38(6):491-499. PubMed ID: 29038913
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of oncogenic cysteinyl leukotriene receptor 2 as a therapeutic target for uveal melanoma.
Slater K; Hoo PS; Buckley AM; Piulats JM; Villanueva A; Portela A; Kennedy BN
Cancer Metastasis Rev; 2018 Sep; 37(2-3):335-345. PubMed ID: 30094568
[TBL] [Abstract][Full Text] [Related]
34. Metastatic disease from uveal melanoma: treatment options and future prospects.
Carvajal RD; Schwartz GK; Tezel T; Marr B; Francis JH; Nathan PD
Br J Ophthalmol; 2017 Jan; 101(1):38-44. PubMed ID: 27574175
[TBL] [Abstract][Full Text] [Related]
35. Melanoma of the eye: revealing hidden secrets, one at a time.
Shields CL; Kels JG; Shields JA
Clin Dermatol; 2015; 33(2):183-96. PubMed ID: 25704938
[TBL] [Abstract][Full Text] [Related]
36. [DEVELOPMENT AND CHALLENGES IN TREATMENT OF UVEAL MELANOMA].
Zloto O; Vishnevskia-Dai V; Moisseiev J; Fabian ID
Harefuah; 2018 Feb; 157(2):95-98. PubMed ID: 29484864
[TBL] [Abstract][Full Text] [Related]
37. Management of posterior uveal melanoma: past, present, and future: the 2014 Charles L. Schepens lecture.
Shields JA; Shields CL
Ophthalmology; 2015 Feb; 122(2):414-28. PubMed ID: 25439609
[TBL] [Abstract][Full Text] [Related]
38. Evolving systemic targeted therapy strategies in uveal melanoma and implications for ophthalmic management: a review.
Goh AY; Layton CJ
Clin Exp Ophthalmol; 2016 Aug; 44(6):509-19. PubMed ID: 26601795
[TBL] [Abstract][Full Text] [Related]
39. Immunotherapy for Uveal Melanoma - Current Knowledge and Perspectives.
Kaštelan S; Antunica AG; Oresković LB; Pelčić G; Kasun E; Hat K
Curr Med Chem; 2020; 27(8):1350-1366. PubMed ID: 31272342
[TBL] [Abstract][Full Text] [Related]
40. Obstacles to improving outcomes in the treatment of uveal melanoma.
Tsai KK; Bollin KB; Patel SP
Cancer; 2018 Jul; 124(13):2693-2703. PubMed ID: 29579316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]